Cerebrospinal fluid as liquid biopsy for characterizing & policing of medulloblastoma
(Vall d'Hebron Institute of Oncology) Building on previous research led by Joan Seoane, Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor, latest findings from a proof-of-concept study published inNature Communications, show that the analysis of cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA), allows for the more precise characterization, molecular diagnosis (including subtyping and risk stratification), and real time tracking of medulloblastoma (MB) - the most prevalent malignant brain tumor in childhood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 27, 2020 Category: International Medicine & Public Health Source Type: news

UCalgary researchers discover new tactic to stop the growth of a deadly brain cancer
(University of Calgary) UCalgary scientists and members of the Clark H. Smith Brain Tumour Centre at the Arnie Charbonneau Cancer Institute at the Cumming School of Medicine have discovered a way to stop the growth of glioblastoma, the deadliest form of brain cancer. The finding, published inNature Communications, provides a new tactic in the war against cancer that involves reprogramming the immune system to do what it does best - fight the tumour instead of fueling it. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2020 Category: Cancer & Oncology Source Type: news

Proton therapy cuts radiation-induced heart disease risk
Using proton therapy to treat lung cancer patients may help reduce the risk...Read more on AuntMinnie.comRelated Reading: IMV: Radiation therapy volume stays steady despite COVID-19 Hyperfine partners with Nvidia, Penn Medicine on portable MRI system New studies laud benefits of proton therapy for kids Proton therapy works well for pediatric brain tumors ASTRO: AI's rad therapy future is in predicting outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 23, 2020 Category: Radiology Source Type: news

When is a headache a sign of a brain tumour? Everything you need to know
BRAIN TUMOUR symptoms depend on the exact part of the brain affected and how slowly or quickly the tumour grows. Headaches are a commonly reported symptom, but how can you tell a regular headache from one associated with a brain tumour? (Source: Daily Express - Health)
Source: Daily Express - Health - October 22, 2020 Category: Consumer Health News Source Type: news

Highly effective tumor detection strategy for common childhood brain tumors
(Texas A&M University) A team of scientists at Texas A&M University, Baylor College of Medicine and Texas Children's Hospital have developed a way to more accurately both detect and monitor a common type of pediatric brain cancer, setting the stage for giving clinicians a real-time view into how the cancer responds to treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 21, 2020 Category: Cancer & Oncology Source Type: news

Tumor DNA in spinal fluid could help doctors better monitor childhood brain cancer
(Michigan Medicine - University of Michigan) Researchers have demonstrated that a new liquid biopsy approach overcomes traditional barriers to quickly and efficiently diagnose and monitor high-grade pediatric gliomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 21, 2020 Category: Cancer & Oncology Source Type: news

The implications of brain tumors on aggressive behavior and suicidality: a review - Lupton A, Abu-Suwa H, Bolton GC, Golden C.
The medical side effects of brain tumors have been studied rather extensively for the development of accurate diagnosis and effective treatments; however, the psychological implications of the various tumor types are vastly understudied. There has been mix... (Source: SafetyLit)
Source: SafetyLit - October 20, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Breakthrough blood test developed for brain tumors
(Massachusetts General Hospital) Genetic mutations that promote the growth of the most common type of adult brain tumors can be accurately detected and monitored in blood samples using an enhanced form of liquid biopsy developed by researchers at Massachusetts General Hospital (MGH). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 14, 2020 Category: International Medicine & Public Health Source Type: news

Tom Parker health: Wanted star diagnosed with a brain tumour - symptoms to look for
TOM PARKER, 32, is best known for his chart-topping success in the British-Irish boy band The Wanted. The star shocked fans yesterday when it was revealed he had a stage 4 brain tumour. What are the symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - October 13, 2020 Category: Consumer Health News Source Type: news

Man pleads guilty after driving against doctor's orders and killing mother of 3
Calgary's James Beagrie, who knew he had a brain tumour that caused him to black out but rejected his doctor's order not to drive and ended up killing a mother of three, pleaded guilty Monday to dangerous driving causing death. (Source: CBC | Health)
Source: CBC | Health - September 28, 2020 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

PET shows promise for detecting NSCLC recurrence
F-18 FDG PET/CT shows promise for detecting recurrence of disease in non-small...Read more on AuntMinnie.comRelated Reading: PET radiomics tailor head/neck cancer treatment Nuclear medicine volume plummets due to COVID-19 Dual-phase technique improves PET/CT brain tumor imaging PET/CT could be useful for diagnosing fever PET/MRI ups lesion detection by 15% for some cancers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 17, 2020 Category: Radiology Source Type: news

NIH funds research into differences in glioblastoma between males and females
(Cleveland Clinic) A team led by researchers from Case Western Reserve University School of Medicine and Cleveland Clinic Lerner Research Institute has secured $10.4 million over five years from the National Institutes of Health/National Cancer Institute to explore at the molecular level the differences in glioblastoma between males and females. The researchers will delve into the genetics, epigenetics and cell biology of glioblastoma - the most common and deadliest brain tumor in adults - to better understand the physiologic processes which may lead to more personalized therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 17, 2020 Category: Cancer & Oncology Source Type: news

PET agent shows promise for imaging lung inflammation
An experimental PET imaging agent shows promise for imaging inflammation in...Read more on AuntMinnie.comRelated Reading: FET-PET offers more info on treatment of brain metastases PET radiomics tailor head/neck cancer treatment Nuclear medicine volume plummets due to COVID-19 Dual-phase technique improves PET/CT brain tumor imaging PET/CT could be useful for diagnosing fever (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 16, 2020 Category: Radiology Source Type: news

FET-PET offers more info on treatment of brain metastases
Using PET with the radiolabeled amino acid F-18 fluoroethyl-tyrosine (F-18-FET)...Read more on AuntMinnie.comRelated Reading: FET-PET can be useful for glioma evaluations FET-PET adds 'relevant' info to pediatric cancer cases SNMMI: FET-PET could have answers for brainstem glioma SNMMI: FET-PET aids pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 14, 2020 Category: Radiology Source Type: news

PET radiomics tailor head/neck cancer treatment
Radiomic factors -- that is, image-based tumor phenotypes -- gleaned from F-18...Read more on AuntMinnie.comRelated Reading: Dual-phase technique improves PET/CT brain tumor imaging PET/CT could be useful for diagnosing fever PET/MRI ups lesion detection by 15% for some cancers Radiomics can predict treatment outcome for NSCLC (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 10, 2020 Category: Radiology Source Type: news

Dual-phase technique improves PET/CT brain tumor imaging
Using a dual-phase technique with F-18 FDG PET/CT -- that is, performing the...Read more on AuntMinnie.comRelated Reading: PET/CT could be useful for diagnosing fever SNMMI 2020: PSMA-PET/CT changes prostate cancer management SNMMI 2020: PET tracer could image, treat glioblastoma PET/CT confirms breast cancer predicted by blood markers New PET/CT tracer reliably detects prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 3, 2020 Category: Radiology Source Type: news

Long sick leave after low-grade brain tumor
(University of Gothenburg) One year after the diagnosis of low-grade malignant brain tumor, a University of Gothenburg study shows, just under three people in ten were in full-time employment. Another year later, the proportion remained below half. For this young patient group, returning to work is a key health factor. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 2, 2020 Category: International Medicine & Public Health Source Type: news

Brain tumor drug receives rare disease designations from the FDA
(Oklahoma Medical Research Foundation) The Food and Drug Administration has given Orphan Disease Designation and Rare Pediatric Disease Designation to OKN-007, an experimental brain cancer treatment currently in Phase 2 clinical trials at eight U.S. sites. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 2, 2020 Category: Cancer & Oncology Source Type: news

The road to recovery: a pilot study of driving behaviors following antibody-mediated encephalitis - Day GS, Babulal GM, Rajasekar G, Stout S, Roe CM.
INTRODUCTION: Safe driving requires integration of higher-order cognitive and motor functions, which are commonly compromised in patients with antibody-mediated encephalitis (AME) associated with N-methyl-D-aspartate receptors or leucine-rich glioma-inacti... (Source: SafetyLit)
Source: SafetyLit - August 31, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Genomic analysis predicts survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in low-grade gliomas in NRG Oncology clinical trial
(NRG Oncology) A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 31, 2020 Category: Cancer & Oncology Source Type: news

FEFU scientists are developing genetic methods to understand malignant tumors
(Far Eastern Federal University) Scientists of Far Eastern Federal University (FEFU University) get started studying the formation and survival mechanisms of the brain malignant tumors cells, i.e. glioma, to reveal new ways for diagnosis and therapy for this fatal disease. This research was supported by the grant from Russian Science Foundation (RSF). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 31, 2020 Category: Cancer & Oncology Source Type: news

Imaging Biometrics added to Arterys marketplace
Advanced visualization software firm Imaging Biometrics has partnered with...Read more on AuntMinnie.comRelated Reading: Imaging Biometrics touts IB-Neuro recognition Imaging Biometrics secures $2.57M grant AI Metrics joins forces with Imaging Biometrics Imaging Biometrics nets NIH grant Imaging Biometrics points to brain tumor study (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 25, 2020 Category: Radiology Source Type: news

Drugs against alpha-ketoglutarate may combat deadly childhood brain tumor
NIH funded pre-clinical study highlights intricate links between brain tumors and cancer. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - August 18, 2020 Category: American Health Source Type: news

Drugs against alpha-ketoglutarate may combat deadly childhood brain tumor
(NIH/National Institute of Neurological Disorders and Stroke) Every year, 150 to 300 children in the United States are diagnosed with diffuse intrinsic pontine gliomas (DIPGs), aggressive and lethal tumors that grow deep inside the brain, for which there are no cures. In a study funded by the National Institutes of Health, researchers showed that experimental drugs designed to lower the body's natural production of alpha-ketoglutarate extended the lives of mice harboring DIPG tumors by slowing the growth of the cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 18, 2020 Category: Cancer & Oncology Source Type: news

The structural basis of Focal Adhesion Kinase activation on lipid membranes unravelled
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) * Patients with glioma - a very common type of tumour originating in the brain - see improvement in survival rates with combined treatment of radiotherapy plus temozolomide* Researchers found a novel mechanism on how tumours evade chemotherapy through genomic rearrangements of the MGMT DNA repair gene* This finding is potentially relevant for updating the methods used to monitor temozolomide efficacy. Genomic rearrangement could be a marker to be detected in blood samples and help make therapeutic decisions (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 11, 2020 Category: Cancer & Oncology Source Type: news

Coming to Terms with Unreality
When I was 14 years old, I entered my freshman year of high school feeling nothing but a dull sense of disquietude. I was not happy to be starting the new school year. I was always “the quiet kid”, and that label only rang truer over time, as I retreated further into my shell with each passing school year. I had few friends, and the ones I had were fair-weather, frequently passing up hanging out with me in favor of others. I knew in the back of my mind that I should feel stressed or upset when the year began, but I just felt empty.  My late childhood and early adolescence, meant to be a time of growth and ...
Source: Psych Central - August 6, 2020 Category: Psychiatry Authors: Renee Consorte Tags: Dissociative disorders Personal Stories Adolescence Depersonalization Derealization Dissociation Resentment Social Anxiety Source Type: news

Study: Topical minoxidil reverses hair loss caused by radiation for brain, head, neck cancers
Treatment with topical minoxidil helps restore hair loss caused by radiation treatment for brain tumors and other head and neck cancers, a study published Wednesday by JAMA Dermatology found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 5, 2020 Category: Consumer Health News Source Type: news

A research team of the CNIO and the HKUST identifies how some gliomas develop chemoresistance
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) * Patients with glioma - a very common type of tumour originating in the brain - see improvement in survival rates with combined treatment of radiotherapy plus temozolomide* Researchers found a novel mechanism on how tumours evade chemotherapy through genomic rearrangements of the MGMT DNA repair gene* This finding is potentially relevant for updating the methods used to monitor temozolomide efficacy. Genomic rearrangement could be a marker to be detected in blood samples and help make therapeutic decisions (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 4, 2020 Category: Cancer & Oncology Source Type: news

Study suggests new approach to improve radiation therapy resistance in glioblastoma
(Michigan Medicine - University of Michigan) Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against glioblastoma, an aggressive type of brain tumor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 30, 2020 Category: Cancer & Oncology Source Type: news

New study: Brain tumors may be seeded from distant site
(Children's National Hospital) A mouse model of glioblastoma, an aggressive type of cancer that can occur in the brain, suggests that this recalcitrant cancer originates from a pool of stem cells that can be a significant distance away from the resulting tumors. The findings of a new study, led by Children's National Hospital researchers and published July 22 in the journal Nature Communications, suggest new ways to fight this deadly disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2020 Category: International Medicine & Public Health Source Type: news

Loyola researchers identify common characteristics of rare pediatric brain tumors
(Loyola University Health System) In a new study, researchers at Loyola University Medical Center and Loyola University Chicago Stritch School of Medicine found that pediatric acoustic neuroma patients had similar symptoms to those of adult patients; however, tumor size was typically larger in the pediatric patients at the time of diagnosis, symptoms of mass effect (secondary effects caused by the tumor) were more common, and the pediatric patients had a higher rate of tumor regrowth. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2020 Category: International Medicine & Public Health Source Type: news

Pre-brain surgery test protects language in some tumors
(Nagoya University) A preoperative procedure might enable surgeons to protect the language centers during brain tumor removal without needing to keep patients awake during surgery. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 16, 2020 Category: International Medicine & Public Health Source Type: news

Unexpected associations found between drug response and cell changes in brain cancer
(Uppsala University) Therapies for treating glioblastoma brain cancer can be delivered with greater precision and existing drugs can be used in new ways. These are the conclusions from a study from Uppsala University investigating a large number of cell samples from patients with brain tumours. The researchers have characterised how changes in glioblastoma cells influence the effect of different drugs. Their findings are published in the journal Cell Reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 14, 2020 Category: Cancer & Oncology Source Type: news

New PET radiotracer proven safe and effective in imaging malignant brain tumors
(Society of Nuclear Medicine and Molecular Imaging) A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting has demonstrated the safety, favorable pharmacokinetic and dosimetry profile of 64Cu-EBRGD, a new, relatively long-lived PET tracer, in patients with glioblastomas. The radiotracer proved to be a superior, high-contrast imaging diagnostic in patients, visualizing tumors that express low or moderate levels ofαvβ3 integrin with high sensitivity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2020 Category: International Medicine & Public Health Source Type: news

New treatment approach uses killer cells to treat deadly brain tumors
(Purdue University) A Purdue University cancer innovator and his team have developed a promising new approach to treating glioblastomas using a type of immune cell called the natural killer (NK) cell. The team genetically modifies the NK cells to more specifically target and kill cancer cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2020 Category: International Medicine & Public Health Source Type: news

Outpatient Brain Tumor Surgery Feasible, Safe Outpatient Brain Tumor Surgery Feasible, Safe
In carefully selected patients who have few comorbidities, outpatient treatment may be appropriate and preferable for brain tumor resection during the COVID-19 pandemic.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - July 8, 2020 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

New treatment strategy may benefit patients with brain cancer
(Massachusetts General Hospital) A team led by investigators at Massachusetts General Hospital has uncovered a potentially promising strategy to treat gliomas with mutations in the IDH genes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2020 Category: Cancer & Oncology Source Type: news

St. Jude creates resource for pediatric brain tumor research
(St. Jude Children's Research Hospital) Researchers worldwide can access orthotopic patient-derived xenograft models to speed discovery and test novel therapies for childhood brain tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 23, 2020 Category: International Medicine & Public Health Source Type: news

New radioisotope therapy treats pediatric neuroblastoma
Japanese researchers have discovered a new radioisotope therapy for children...Read more on AuntMinnie.comRelated Reading: Researchers link brain tumor treatment to GBCA deposition AJR paper describes errors in pediatric radiography Whole-body MRI has mixed results in pediatric cancer patients Dell donates cloud cluster for pediatric cancer trial Protocols protect pediatric caregivers from I-131 exposure (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2020 Category: Radiology Source Type: news

Imaging Biometrics touts IB-Neuro recognition
Advanced visualization software firm Imaging Biometrics is touting the recognition...Read more on AuntMinnie.comRelated Reading: Imaging Biometrics secures $2.57M grant AI Metrics joins forces with Imaging Biometrics Imaging Biometrics nets NIH grant Imaging Biometrics points to brain tumor study Imaging Biometrics teams with CorTechs Labs (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2020 Category: Radiology Source Type: news

Focused ultrasound shows promise against deadliest brain tumor
(University of Virginia Health System) Focused sound waves create tiny bubbles inside cancer cells, causing them to die. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2020 Category: International Medicine & Public Health Source Type: news

Diagnosing brain tumors with a blood test
(University Health Network) A simple but highly sensitive blood test has been found to accurately diagnose and classify different types of brain tumours, resulting in more accurate diagnosis, less invasive methods and better treatment planning in the future for the patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2020 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Announces Winners of 2020 Women in STEM2D Scholars Award
(New Brunswick, N.J. – June 18) – Johnson & Johnson today announced the six winners of the third annual Johnson & Johnson Women in STEM2D (WiSTEM2D) Scholars Award. Each recipient, representing each of the STEM2D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design, will receive a grant of $150,000 and three years of mentorship. Launched in June 2017, the Johnson & Johnson WiSTEM2D Scholars Award seeks to fuel development of future female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their careers. The goal is to su...
Source: Johnson and Johnson - June 18, 2020 Category: Pharmaceuticals Source Type: news

CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
HOUSTON, June 11, 2020 -- (Healthcare Sales & Marketing Network) -- CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and me... Biopharmaceuticals, Oncology, Neurology, FDA CNS Pharmaceuticals, Berubicin, glioma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2020 Category: Pharmaceuticals Source Type: news

Artificial intelligence enhances brain tumour diagnosis
(Kyoto University) A new machine learning approach classifies a common type of brain tumour into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access. Scientists in India and Japan, including from Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS), developed the method to help clinicians choose the most effective treatment strategy for individual patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2020 Category: International Medicine & Public Health Source Type: news

New method to identify genes that can drive development of brain tumors
(Uppsala University) Researchers at Uppsala University have developed a method for identifying functional mutations and their effect on genes relevant to the development of glioblastoma. The results show that a specific, evolutionarily conserved, mutation in the vicinity of SEMA3C disrupts the binding of certain proteins whose task is to bind genes and regulate their activity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 9, 2020 Category: Cancer & Oncology Source Type: news

Imaging Biometrics secures $2.57M grant
Advanced visualization software firm Imaging Biometrics has received a five-year,...Read more on AuntMinnie.comRelated Reading: AI Metrics joins forces with Imaging Biometrics Imaging Biometrics nets NIH grant Imaging Biometrics points to brain tumor study Imaging Biometrics teams with CorTechs Labs Imaging Biometrics debuts IB Server software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 8, 2020 Category: Radiology Source Type: news

Scientists discover that nicotine promotes spread of lung cancer to the brain
(Wake Forest Baptist Medical Center) Among people who have the most common type of lung cancer, up to 40% develop metastatic brain tumors, with an average survival time of less than six months. But why non-small-cell lung cancer so often spreads to the brain has been poorly understood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2020 Category: International Medicine & Public Health Source Type: news

Continued nicotine use promotes brain tumors in lung cancer patients, study suggests
(Rockefeller University Press) Researchers have discovered that nicotine promotes the spread of lung cancer cells into the brain, where they can form deadly metastatic tumors. The study, which will be published June 4 in the Journal of Experimental Medicine, suggests that nicotine replacement therapies may not be suitable strategies for lung cancer patients attempting to quit smoking. In addition, the researchers show that the naturally occurring drug parthenolide blocks nicotine-induced brain metastasis in mice, suggesting a potential therapeutic option in humans. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 4, 2020 Category: International Medicine & Public Health Source Type: news

Ludwig Lausanne study charts the immune landscape of multiple brain cancers
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has profiled, in a sweeping comparative analysis, the distinct immune landscapes of tumors that arise in the brain, or gliomas, and those that metastasize to the organ from the lungs, breast and skin. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 28, 2020 Category: Cancer & Oncology Source Type: news